UPMC HAMOT — History
CCN 390063 | 3-year financial timeline | COVID resilience: 35/100
🛡️ Public data only — no PHI permitted on this instance.
$508M
Latest Revenue (FY2022)
+1.6%
Revenue CAGR (3yr)
-11.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $492M | $505M | $508M | +0.5% | +1.6% |
| Operating Expenses | $466M | $529M | $564M | +6.5% | +10.0% |
| Operating Margin | 5.1% | -4.7% | -11.0% | -134.3% | +0.0% |
| Net Income | $25M | $-24M | $-56M | -135.4% | +0.0% |
| Licensed Beds | 456 | 456 | 456 | +0.0% | +0.0% |
| Total Patient Days | 106,060 | 110,714 | 103,232 | -6.8% | -1.3% |
| Medicare Day % | 26% | 24% | 22% | -6.5% | -8.2% |
| Medicaid Day % | 5% | 5% | 5% | +1.7% | +2.6% |
COVID Impact & Recovery
Resilience Score: 35/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +3.3% ($492M → $508M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.6%
This Hospital
+7.6%
State Avg
Latest Margin
-11.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $516M | -19.1% |
| FY2024 (proj) | $524M | -27.1% |
| FY2025 (proj) | $532M | -35.2% |